Home › Kanser sa Ulo at Leeg › Massachusetts › Boston
Pag-aaral pangklinika para sa Kanser sa Ulo at Leeg sa Boston, MA
Isang pag-aaral para sa Kanser sa Ulo at Leeg ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Boston. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Nagre-recruitPhase 1/2
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
Nagre-recruitPhase 2/3
- Site #0131, Boston
- Site#0101, Boston
Distance-Based Exercise to Preserve Function and Prevent Disability
Nagre-recruit
- Dana-Farber Cancer Institute, Boston
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Nagre-recruitPhase 1
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
Nagre-recruitPhase 1/2
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
Toripalimab With Chemotherapy for Sinus Cancer
Nagre-recruitPhase 2
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
PD-L1 t-haNK, NAI IL-15sa and Cetuximab for Recurrent, Metastatic HNSCC
Nagre-recruitPhase 2
- Brigham and Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1/2
- Massachusetts General Hospital Cancer Center, Boston
Jump: MR Simulation For Radiation Therapy Master Protocol
Nagre-recruit
- Brigham and Women Hospital, Boston
- Dana Farber Cancer Institute, Boston
PDT For Induction Therapy For Head And Neck Cancer
Nagre-recruitPhase 2
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1/2
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Clonal Hematopoiesis Chemotherapy and Radiation Effects Study
Nagre-recruitObservasyonal na pag-aaral
- Dana-Farber Cancer Institute, Boston
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1/2
- Beth Israel Deaconess Medical Center, Boston
- Dana-Farber Cancer Institute, Boston
Preoperative Pembrolizumab and Chemotherapy in Resectable, Recurrent HNSCC
Nagre-recruitPhase 2
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Nagre-recruitPhase 1/2
- Massachusetts General Hospital,, Boston
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Nagre-recruitPhase 1/2
- Massachusetts General Hospital, Boston
Study of De_Intensified Postoperative Radiation Therapy for HPV Associated Oropharyngeal Squamous Cell Carcinoma
Nagre-recruit
- Dana Farber Cancer Institute, Boston
Stereotactic MRI-guided Focused Ultrasound Mesencephalotomy
Nagre-recruit
- Brigham and Women's Hospital, Boston
Drug Screening Using Novel IMD in Salivary and Head and Neck Cancers
Nagre-recruitMaagang Phase 1
- Brigham and Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
Nagre-recruitPhase 1/2
- Dana Farber Cancer Institute, Boston
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
Nagre-recruitPhase 1
- Dana Farber/Partners Cancer Care Inc, Boston
Comprehensive Outcomes for After Cancer Health
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- Dana Farber Cancer Institute, Boston
Pag-aaral para sa Kanser sa Ulo at Leeg sa ibang lungsod
- Houston, TX30 pag-aaral
- New York City, NY21 pag-aaral
- Nashville, TN21 pag-aaral
- St. Louis, MO15 pag-aaral
- Dallas, TX12 pag-aaral
- Pittsburgh, PA11 pag-aaral
- San Antonio, TX10 pag-aaral
- Los Angeles, CA10 pag-aaral
- Baltimore, MD10 pag-aaral
- Washington, DC10 pag-aaral
- Durham, NC10 pag-aaral
- Chicago, IL10 pag-aaral
Iba pang pag-aaral sa Boston
- Kanser sa Suso112 pag-aaral
- Non-Small Cell Lung Cancer90 pag-aaral
- Kanser (lahat ng uri)85 pag-aaral
- Metastatic Cancer63 pag-aaral
- Colorectal Cancer63 pag-aaral
- Kanser sa Baga62 pag-aaral
- Kanser sa Ovary61 pag-aaral
- Kanser sa Prostate59 pag-aaral
- Depression52 pag-aaral
- Kanser ng Endometrium50 pag-aaral
- Pagkabigo ng Puso44 pag-aaral
- Acute Myeloid Leukemia44 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.